Tweet
Lobster Head is a lifestyle and a way of looking at the world.
Lobster Head is universal and transcends this universe, expanding infinitely into all universes.
Lobster Head is not only beyond time and space, Lobster Head IS time and space.
Lobster Head is not a religion, but it is the worship of all religions. Lobster Head has always, and will always be.
Lobster Head is love. Lobster Head is hate.
The most important thing to remember is that Lobster Head is forever, the rest will just fall into place.
Before we go on and on singing the virtues of Lobster Head, you need to know that Lobster Head doesn’t transcend $$$MR. MARKET$$$. Why? Because $$$MR. MARKET$$$ is HUGE..that’s why… and $$$MR. MARKET$$$ is about to transcend the market with a brand new pick. Let’s get a report from a surgeon in the Sunshine State.
All surgeons are busy seeing patients and operating, we have no time for paperwork we need to dictate on the run with a cell phone in hand. Transcend (TRCR) to the rescue.... on the way to the links for our noon tee time we can drive the Cararra with our knee, pound a roadie and dictate the mornings work to the cloud and TRCR sends the completed note to the orifice by the time you make the turn at # 10. A more formal way of saying this is: TRCR is a technology-enabled clinical documentation services company that provides services and technology to hospitals that enable physicians to efficiently document patient care using advanced technology that converts narrative content into meaningful clinical information which includes:
· Dictation Capture
· Report Creation
· Distribution
Today I bought TRCR at 29.48. I will sell it in 4 – 6 weeks at 33.97. Here’s why I like TRCR:
This stock is up 117% in the last 52 weeks and it is a growth company for sure. Organic or by acquisition, they are filling a electronic need that has existed for a very long time. The trailing PE may be near 30 but the forward PE is only 19. Also, even with that P/E we are still getting a PEG ratio of 1.0, which is a bargain.
This sucker is going to grow and grow.
Transcend Services, Inc. provides medical transcription services to the healthcare industry in the United States. It converts physicians voice recordings into electronic medical record documents using its proprietary BeyondTXT workflow platform that provides workflow management and production control. The company utilizes a combination of its proprietary Internet-based voice and data distribution technology, customer based technology, and home-based medical language specialists to convert physicians’ voice recordings into electronic documents. It also offers its medical transcription services directly on the customers’ platforms. The company serves hospitals and clinics. Transcend Services was founded in 1976 and is based in Atlanta, Georgia
“We’re excited to share this new platform with healthcare providers and show them how it can reduce overhead, streamline productivity and accelerate the meaningful use of electronic health records (EHRs),” comments Susan McGrogan, Transcend’s President and Chief Operating Officer. It also allows our customers direct access to the speech recognition benefits of our partner, MultiModal Technologies. This technology, coupled with our training, promises cost savings through improved productivity. Encore, which was built to accommodate the healthcare industry’s drive to XML data, tags and structures narrative data so that information is easily integrated into a patient’s EHR and may be queried for quality reporting.”
“The bottom line with Encore is that we really listened to our transcriptionists who produce clinical documentation all day long, and we incorporated their ‘wish lists’ into the Encore platform solution,” McGrogan notes. “From customizable command/short-cut keys to Windows-based menus to backups done on our servers to prevent work loss due to a computer crash – we offer it all.”
Transcend just beat earnings expectations on May 5 when it reported earnings per share of $0.34 compared to the ANAL-ysts’ Estimates of $0.28. This gives Transcend back to back earnings surprises.
Revenue was up 32% to $29.3 million, on a year over year basis, driven by surging volumes. Transcend said it “dramatically exceeded” its own outlook.
The recent acquisition of DTS adds instant accretive earnings and growth that cements Transcend’s position as a market leader. Susan McGrogan noted that business will continue as usual for DTS customers and employees, many of whom Transcend executives were able to meet after the pending acquisition was announced on March 3rd. “We are excited for this opportunity to service our new customers and welcome new employees to the Transcend team, and we are confident we will be able to meet and exceed their expectations. We will be able to offer our DTS customers a greater array of flexible solutions to support their future clinical documentation needs,” she said.
What are some of the investment highlights that makes these guys tick?:
The organic growth is going to come from
Even better is that TRCR experienced 98 percent retention for 2010. Customer retention and satisfaction remain the primary goal of every employee at Transcend. They work very hard to exceed customers’ expectations and consistently ask them what they can do to improve their services and add value to them in this ever-changing healthcare environment
Another trend they see in the industry is standardization (among) hospitals in many areas, with transcription being just one of them. Transcend’s size and our technology makes them only one of few vendors that a bigger system would look at. This allows a hospital system not only cost savings, but flexibility of solutions and system-wide access to data that their technology generates.
What does this add up to? Since 2004, TRCR has grown its revenues from $15.2 MM to $94.3 MM in 2010. That’s a 36% CAGR. Even more impressive is the earnings growth which has climbed from $2.0 MM in 2006 to to $14.4 MM in 2010. That’s a 63% CAGR.
Is past performance any indication of the future. Well, in this case….yes. ANAL-ysts are calling for earnings per share of $1.36 in 2011 generated from their projected revenues of $128 MM. Come on boys! You can do better than that! This company is a wrecking machine and it cannot be stopped.
$$$MR. MARKET$$$ has sniffed our revenues of $135 MM for the year…but don’t forget the margin growth. Margins are at an all time high of 39% which is going to really propel these revenues to the bottom line. That means we’ll see earnings of $1.64 per share in 2011. If you take today’s PE of 30 and multiply it by $1.64, that gets you a share price of 49.20 which would make Chief Knockahoma run around his teepee. Yessiree Bob I’m gonna do it again.
Here’s what the head honchos at Transcend have to say:
Susan McGrogan, President and Chief Operating Officer, stated: “We dramatically exceeded our own expectations in the first quarter. Revenue was above expectations due to strong volume, which we often see this time of year. I also want to highlight the fact that we achieved a 40% gross profit margin for the first time. One reason for this is our success in the use of speech recognition technology. The 40% gross profit margin threshold was a long-standing “stretch” goal for us and I’m extremely proud of what our teams have achieved, especially in a very competitive, price-sensitive environment.”
Lance Cornell, Chief Financial Officer, added: “ With our highly liquid balance sheet and strong cash flow from operations, we believe we are well-positioned to take advantage of acquisitions and other business opportunities as they arise.”
Larry Gerdes, Chief Executive Officer, concluded: “Our first quarter 2011 results were tremendous, and I want to thank all of our employees for their contributions and hard work. As we look forward, we will remain focused first and foremost on providing excellent service to our customers and second on ensuring that Transcend is the best place to work in the industry. We will also focus heavily on our product development efforts, including the launch of our new Encore transcription platform and physician self-editing solutions. We are excited about positioning ourselves to provide innovative clinical documentation solutions for our customers as we work to help them achieve meaningful use of electronic medical records.”
Look, while all those doctors are out on the golf course, we have to make sure some of this data is being recorded properly. TRCR is going to take care of that, so that our fine medical facilities can take care of us. And with insurance premiums on the rise, we’re going to need the money we make on this stock to help us out a little.
I am HUGE!!
$$$MR. MARKET$$$
www.mrmarketishuge.com
Lobster Head is universal and transcends this universe, expanding infinitely into all universes.
Lobster Head is not only beyond time and space, Lobster Head IS time and space.
Lobster Head is not a religion, but it is the worship of all religions. Lobster Head has always, and will always be.
Lobster Head is love. Lobster Head is hate.
The most important thing to remember is that Lobster Head is forever, the rest will just fall into place.
Before we go on and on singing the virtues of Lobster Head, you need to know that Lobster Head doesn’t transcend $$$MR. MARKET$$$. Why? Because $$$MR. MARKET$$$ is HUGE..that’s why… and $$$MR. MARKET$$$ is about to transcend the market with a brand new pick. Let’s get a report from a surgeon in the Sunshine State.
All surgeons are busy seeing patients and operating, we have no time for paperwork we need to dictate on the run with a cell phone in hand. Transcend (TRCR) to the rescue.... on the way to the links for our noon tee time we can drive the Cararra with our knee, pound a roadie and dictate the mornings work to the cloud and TRCR sends the completed note to the orifice by the time you make the turn at # 10. A more formal way of saying this is: TRCR is a technology-enabled clinical documentation services company that provides services and technology to hospitals that enable physicians to efficiently document patient care using advanced technology that converts narrative content into meaningful clinical information which includes:
· Dictation Capture
· Report Creation
· Distribution
Today I bought TRCR at 29.48. I will sell it in 4 – 6 weeks at 33.97. Here’s why I like TRCR:
This stock is up 117% in the last 52 weeks and it is a growth company for sure. Organic or by acquisition, they are filling a electronic need that has existed for a very long time. The trailing PE may be near 30 but the forward PE is only 19. Also, even with that P/E we are still getting a PEG ratio of 1.0, which is a bargain.
This sucker is going to grow and grow.
Transcend Services, Inc. provides medical transcription services to the healthcare industry in the United States. It converts physicians voice recordings into electronic medical record documents using its proprietary BeyondTXT workflow platform that provides workflow management and production control. The company utilizes a combination of its proprietary Internet-based voice and data distribution technology, customer based technology, and home-based medical language specialists to convert physicians’ voice recordings into electronic documents. It also offers its medical transcription services directly on the customers’ platforms. The company serves hospitals and clinics. Transcend Services was founded in 1976 and is based in Atlanta, Georgia
“We’re excited to share this new platform with healthcare providers and show them how it can reduce overhead, streamline productivity and accelerate the meaningful use of electronic health records (EHRs),” comments Susan McGrogan, Transcend’s President and Chief Operating Officer. It also allows our customers direct access to the speech recognition benefits of our partner, MultiModal Technologies. This technology, coupled with our training, promises cost savings through improved productivity. Encore, which was built to accommodate the healthcare industry’s drive to XML data, tags and structures narrative data so that information is easily integrated into a patient’s EHR and may be queried for quality reporting.”
“The bottom line with Encore is that we really listened to our transcriptionists who produce clinical documentation all day long, and we incorporated their ‘wish lists’ into the Encore platform solution,” McGrogan notes. “From customizable command/short-cut keys to Windows-based menus to backups done on our servers to prevent work loss due to a computer crash – we offer it all.”
Transcend just beat earnings expectations on May 5 when it reported earnings per share of $0.34 compared to the ANAL-ysts’ Estimates of $0.28. This gives Transcend back to back earnings surprises.
Revenue was up 32% to $29.3 million, on a year over year basis, driven by surging volumes. Transcend said it “dramatically exceeded” its own outlook.
The recent acquisition of DTS adds instant accretive earnings and growth that cements Transcend’s position as a market leader. Susan McGrogan noted that business will continue as usual for DTS customers and employees, many of whom Transcend executives were able to meet after the pending acquisition was announced on March 3rd. “We are excited for this opportunity to service our new customers and welcome new employees to the Transcend team, and we are confident we will be able to meet and exceed their expectations. We will be able to offer our DTS customers a greater array of flexible solutions to support their future clinical documentation needs,” she said.
What are some of the investment highlights that makes these guys tick?:
- Proven management team
- Large market with strong growth drivers
- Superior customer service model
- Advanced technology drives operating efficiency
- New solutions to meet diverse documentation needs
- Significant acquisition opportunities
- Strong track record of achievement
The organic growth is going to come from
- Public Policy: EHR Stimulus money, healthcare reform, higher utilization
- Aging baby boomers drive increased demand for healthcare
- Trend toward outsourcing of transcription by hospitals
- Fragmented industry poised for consolidation
- New product and service offerings
Even better is that TRCR experienced 98 percent retention for 2010. Customer retention and satisfaction remain the primary goal of every employee at Transcend. They work very hard to exceed customers’ expectations and consistently ask them what they can do to improve their services and add value to them in this ever-changing healthcare environment
Another trend they see in the industry is standardization (among) hospitals in many areas, with transcription being just one of them. Transcend’s size and our technology makes them only one of few vendors that a bigger system would look at. This allows a hospital system not only cost savings, but flexibility of solutions and system-wide access to data that their technology generates.
What does this add up to? Since 2004, TRCR has grown its revenues from $15.2 MM to $94.3 MM in 2010. That’s a 36% CAGR. Even more impressive is the earnings growth which has climbed from $2.0 MM in 2006 to to $14.4 MM in 2010. That’s a 63% CAGR.
Is past performance any indication of the future. Well, in this case….yes. ANAL-ysts are calling for earnings per share of $1.36 in 2011 generated from their projected revenues of $128 MM. Come on boys! You can do better than that! This company is a wrecking machine and it cannot be stopped.
$$$MR. MARKET$$$ has sniffed our revenues of $135 MM for the year…but don’t forget the margin growth. Margins are at an all time high of 39% which is going to really propel these revenues to the bottom line. That means we’ll see earnings of $1.64 per share in 2011. If you take today’s PE of 30 and multiply it by $1.64, that gets you a share price of 49.20 which would make Chief Knockahoma run around his teepee. Yessiree Bob I’m gonna do it again.
Here’s what the head honchos at Transcend have to say:
Susan McGrogan, President and Chief Operating Officer, stated: “We dramatically exceeded our own expectations in the first quarter. Revenue was above expectations due to strong volume, which we often see this time of year. I also want to highlight the fact that we achieved a 40% gross profit margin for the first time. One reason for this is our success in the use of speech recognition technology. The 40% gross profit margin threshold was a long-standing “stretch” goal for us and I’m extremely proud of what our teams have achieved, especially in a very competitive, price-sensitive environment.”
Lance Cornell, Chief Financial Officer, added: “ With our highly liquid balance sheet and strong cash flow from operations, we believe we are well-positioned to take advantage of acquisitions and other business opportunities as they arise.”
Larry Gerdes, Chief Executive Officer, concluded: “Our first quarter 2011 results were tremendous, and I want to thank all of our employees for their contributions and hard work. As we look forward, we will remain focused first and foremost on providing excellent service to our customers and second on ensuring that Transcend is the best place to work in the industry. We will also focus heavily on our product development efforts, including the launch of our new Encore transcription platform and physician self-editing solutions. We are excited about positioning ourselves to provide innovative clinical documentation solutions for our customers as we work to help them achieve meaningful use of electronic medical records.”
Look, while all those doctors are out on the golf course, we have to make sure some of this data is being recorded properly. TRCR is going to take care of that, so that our fine medical facilities can take care of us. And with insurance premiums on the rise, we’re going to need the money we make on this stock to help us out a little.
I am HUGE!!
$$$MR. MARKET$$$
www.mrmarketishuge.com
Comment